Literature DB >> 14745748

Blood oxygenation level-dependent MRI of cerebral gliomas during breath holding.

Yuan-Yu Hsu1, Chen-Nen Chang, Shih-Ming Jung, Kun-Eng Lim, Ju-Chuan Huang, Shin-Yi Fang, Ho-Ling Liu.   

Abstract

PURPOSE: To assess the cerebrovascular responses to short breath holding of cerebral gliomas using blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Six patients with a low-grade glioma and one patient with a high-grade glioma were studied using T2*-weighted echo planar imaging (EPI) during repeated periods of 15-second or 20-second breath-holding. Tumor vascularity was evaluated using dynamic susceptibility contrast perfusion MRI.
RESULTS: Increases in BOLD signal intensity during repeated breath-holding were consistently identified in patients' normal appearing gray matter, comparable with those in healthy adults. Absence of significant BOLD signal enhancement was noted both in low-grade and high-grade gliomas, which is either due to overwhelming hypoxia in a tumor, inadequacy or absence of hypercapnia-induced vasodilatation of tumor vessels, or both. Breath-hold regulated decreases in BOLD signals occurred only in the high-grade glioma, which is most likely due to the hypercapnia-induced steal effect that redistributes blood flow from tumor regions with unresponsive neovasculature to surrounding normal tissue.
CONCLUSION: BOLD MRI during short breath holding can disclose differential cerebrovascular response between normal tissue and cerebral glioma. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745748     DOI: 10.1002/jmri.10447

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  22 in total

Review 1.  Pitfalls in FMRI.

Authors:  Sven Haller; Andreas J Bartsch
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

2.  Intraoperative BOLD-fMRI Cerebrovascular Reactivity Assessment.

Authors:  Giovanni Muscas; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Giuseppe Esposito; Luca Regli; Jorn Fierstra
Journal:  Acta Neurochir Suppl       Date:  2021

Review 3.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI.

Authors:  Domenico Zacà; Jorge Jovicich; Sreenivasan R Nadar; James T Voyvodic; Jay J Pillai
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

5.  Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results.

Authors:  A Müller; S Remmele; I Wenningmann; H Clusmann; F Träber; S Flacke; R König; J Gieseke; W A Willinek; H H Schild; P Mürtz
Journal:  Eur Radiol       Date:  2010-09-22       Impact factor: 5.315

6.  Local Glioma Cells Are Associated with Vascular Dysregulation.

Authors:  S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

7.  Vascular Reactivity Maps in Patients with Gliomas Using Breath-Holding BOLD fMRI.

Authors:  Amir Iranmahboob; Kyung K Peck; Nicole P Brennan; Sasan Karimi; Ryan Fisicaro; Bob Hou; Andrei I Holodny
Journal:  J Neuroimaging       Date:  2016 Mar-Apr       Impact factor: 2.486

8.  On the optimization of imaging protocol for the mapping of cerebrovascular reactivity.

Authors:  Harshan Ravi; Binu P Thomas; Shin-Lei Peng; Hanli Liu; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2015-08-13       Impact factor: 4.813

9.  PET Imaging of Angiogenesis.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  PET Clin       Date:  2009-01-01

Review 10.  Quantitative imaging biomarkers in neuro-oncology.

Authors:  Adam D Waldman; Alan Jackson; Stephen J Price; Christopher A Clark; Thomas C Booth; Dorothee P Auer; Paul S Tofts; David J Collins; Martin O Leach; Jeremy H Rees
Journal:  Nat Rev Clin Oncol       Date:  2009-06-23       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.